{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:06:22Z","timestamp":1791947182584,"version":"4.3.4"},"reference-count":135,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG10161"],"award-info":[{"award-number":["P30 AG10161"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG061356"],"award-info":[{"award-number":["U01 AG061356"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG015819"],"award-info":[{"award-number":["R01 AG015819"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG72975"],"award-info":[{"award-number":["P30 AG72975"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG17917"],"award-info":[{"award-number":["R01 AG17917"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.mcpro.2025.100983","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:43:27Z","timestamp":1746474207000},"page":"100983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Discovery of Proteoforms Associated With Alzheimer's Disease Through Quantitative Top-Down Proteomics"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-3623","authenticated-orcid":false,"given":"James M.","family":"Fulcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Ives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6252-5895","authenticated-orcid":false,"given":"Shane S.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Fillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3575-3224","authenticated-orcid":false,"given":"Mowei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-2827","authenticated-orcid":false,"given":"Wei-Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Pa\u0161a-Toli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6841-4830","authenticated-orcid":false,"given":"Shahram","family":"Oveisgharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-151X","authenticated-orcid":false,"given":"Vladislav A.","family":"Petyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2025.100983_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Dementia Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-022-00523-1","article-title":"Alzheimer's disease - the journey of a healthy brain into organ failure","volume":"17","author":"Golde","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcpro.2025.100983_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcpro.2025.100983_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","article-title":"Biological subtypes of Alzheimer disease: a systematic review and meta-analysis","volume":"94","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.mcpro.2025.100983_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcpro.2025.100983_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer's disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.100983_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","article-title":"Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level","volume":"25","author":"Johnson","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mcpro.2025.100983_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcpro.2025.100983_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8178","article-title":"A brain proteomic signature of incipient Alzheimer's disease in young APOE epsilon4 carriers identifies novel drug targets","volume":"7","author":"Roberts","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mcpro.2025.100983_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev-anchem-071015-041550","article-title":"Progress in top-down proteomics and the analysis of proteoforms","volume":"9","author":"Toby","year":"2016","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/156720512801322573","article-title":"Overview and findings from the religious orders study","volume":"9","author":"Bennett","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2174\/156720512801322663","article-title":"Overview and findings from the rush memory and aging project","volume":"9","author":"Bennett","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.bbamcr.2017.07.002","article-title":"Top-down proteomics for the analysis of proteolytic events - methods, applications and perspectives","volume":"1864","author":"Tholey","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib14","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1021\/acs.analchem.1c05123","article-title":"Improved identification of proteoforms in top-down proteomics using FAIMS with internal CV stepping","volume":"94","author":"Kaulich","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib15","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/acs.jproteome.1c00049","article-title":"Enhancing top-down proteomics of brain tissue with FAIMS","volume":"20","author":"Fulcher","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib16","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In Vitro characterization of conditions for amyloid-\u03b2 peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/acs.jproteome.2c00570","article-title":"TopPICR: a companion R package for top-down proteomics data analysis","volume":"22","author":"Martin","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib18","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1074\/mcp.M113.030114","article-title":"Large-scale top-down proteomics of the human proteome: membrane proteins, mitochondria, and senescence","volume":"12","author":"Catherman","year":"2013","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mcpro.2025.100983_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1126\/science.aaz5284","article-title":"The Blood Proteoform Atlas: a reference map of proteoforms in human hematopoietic cells","volume":"375","author":"Melani","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2025.100983_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.142","article-title":"A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research","volume":"5","author":"De Jager","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.mcpro.2025.100983_bib21","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-179939","article-title":"Religious orders study and rush memory and aging project","volume":"64","author":"Bennett","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcpro.2025.100983_bib22","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.mcpro.2025.100983_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.59.2.198","article-title":"Natural history of mild cognitive impairment in older persons","volume":"59","author":"Bennett","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mcpro.2025.100983_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000096129","article-title":"Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study","volume":"27","author":"Bennett","year":"2006","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mcpro.2025.100983_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib26","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/brain\/awab092","article-title":"To what degree is late life cognitive decline driven by age-related neuropathologies?","volume":"144","author":"Boyle","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.mcpro.2025.100983_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo6764","article-title":"Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer's disease progression and heterogeneity","volume":"8","author":"Iturria-Medina","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mcpro.2025.100983_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-018-0272-6","article-title":"Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain","volume":"13","author":"Felsky","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcpro.2025.100983_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41467-018-08279-3","article-title":"Neuropathological correlates and genetic architecture of microglial activation in elderly human brain","volume":"10","author":"Felsky","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100983_bib30","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/bioinformatics\/btw398","article-title":"TopPIC: a software tool for top-down mass spectrometry-based proteoform identification and characterization","volume":"32","author":"Kou","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mcpro.2025.100983_bib31","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.mcpro.2025.100983_bib33","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/pr100527g","article-title":"Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling","volume":"9","author":"Li","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.mcpro.2025.100983_bib35","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/bioinformatics\/btm069","article-title":"pcaMethods--a bioconductor package providing PCA methods for incomplete data","volume":"23","author":"Stacklies","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mcpro.2025.100983_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/840518","article-title":"Mass spectrometry-based label-free quantitative proteomics","author":"Zhu","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.mcpro.2025.100983_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1586\/epr.09.69","article-title":"Role of spectral counting in quantitative proteomics","volume":"7","author":"Lundgren","year":"2010","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.mcpro.2025.100983_bib38","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1021\/ac2010795","article-title":"On the scalability and requirements of whole protein mass spectrometry","volume":"83","author":"Compton","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib39","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1021\/acs.jproteome.6b00696","article-title":"Identification and characterization of human proteoforms by top-down LC-21 tesla FT-ICR mass spectrometry","volume":"16","author":"Anderson","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib40","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.1073\/pnas.90.21.9857","article-title":"Brain-specific tropomyosins TMBr-1 and TMBr-3 have distinct patterns of expression during development and in adult brain","volume":"90","author":"Stamm","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcpro.2025.100983_bib42","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","article-title":"Mass spectrometry of purified amyloid beta protein in Alzheimer's disease","volume":"267","author":"Mori","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/alzrt121","article-title":"Overlapping profiles of Abeta peptides in the Alzheimer's disease and pathological aging brains","volume":"4","author":"Moore","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.mcpro.2025.100983_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/pmic.201500366","article-title":"Preventing N- and O-formylation of proteins when incubated in concentrated formic acid","volume":"16","author":"Zheng","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2025.100983_bib45","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11426-010-4188-4","article-title":"Hexafluoro-2-propanol as a potent cosolvent for chemical ligation of membrane proteins","volume":"54","author":"Shen","year":"2011","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib47","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1021\/acs.jproteome.3c00353","article-title":"Amyloid beta proteoforms elucidated by quantitative LC\/MS in the 5xFAD mouse model of Alzheimer's disease","volume":"22","author":"Kandi","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib48","doi-asserted-by":"crossref","first-page":"13117","DOI":"10.1073\/pnas.0504184102","article-title":"Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation","volume":"102","author":"Huang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib49","doi-asserted-by":"crossref","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","article-title":"Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease","volume":"286","author":"Jawhar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4929","article-title":"Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease","volume":"243","author":"Wang","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.mcpro.2025.100983_bib51","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1021\/acs.analchem.6b04960","article-title":"Synthesis of a highly azide-reactive and thermosensitive biofunctional reagent for efficient enrichment and large-scale identification of O-GlcNAc proteins by mass spectrometry","volume":"89","author":"Zhang","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib52","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1021\/jacs.1c11041","article-title":"Spatiotemporal activation of protein O-GlcNAcylation in living cells","volume":"144","author":"He","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mcpro.2025.100983_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JAD-215153","article-title":"Diabetes mellitus, elevated hemoglobin A 1c, and glycated albumin are associated with the presence of all-cause dementia and Alzheimer's disease: the JPSC-AD study","volume":"85","author":"Noguchi-Shinohara","year":"2022","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.mcpro.2025.100983_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/ac051207j","article-title":"Global identification of O-GlcNAc-Modified proteins","volume":"78","author":"Nandi","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/cancers14010243","article-title":"Comparative O-GlcNAc proteomic analysis reveals a role of O-GlcNAcylated SAM68 in lung cancer aggressiveness","volume":"14","author":"Lin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.mcpro.2025.100983_bib56","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nchembio.338","article-title":"Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc","volume":"6","author":"Teo","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mcpro.2025.100983_bib57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1878-0261.12406","article-title":"O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma","volume":"13","author":"Phoomak","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mcpro.2025.100983_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-019-0067-4","article-title":"Global profiling of O-GlcNAcylated and\/or phosphorylated proteins in hepatoblastoma","volume":"4","author":"Song","year":"2019","journal-title":"Signal. Transduct. Targeted Ther."},{"key":"10.1016\/j.mcpro.2025.100983_bib59","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/jacs.7b13546","article-title":"O-GlcNAc transferase recognizes protein substrates using an asparagine ladder in the tetratricopeptide repeat (TPR) superhelix","volume":"140","author":"Levine","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mcpro.2025.100983_bib60","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1096-9888(199804)33:4<358::AID-JMS642>3.0.CO;2-3","article-title":"Localization of o-glycosylation sites of MUC1 tandem repeats by QTOF ESI mass spectrometry","volume":"33","author":"Hanisch","year":"1998","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.mcpro.2025.100983_bib61","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1021\/bi9919091","article-title":"Heterogeneous glycosylation of immunoglobulin E constructs characterized by top-down high-resolution 2-D mass spectrometry","volume":"39","author":"Fridriksson","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.mcpro.2025.100983_bib62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.100983_bib63","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.100983_bib64","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1021\/pr301146m","article-title":"Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis","volume":"12","author":"Piehowski","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ana.25266","article-title":"Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia","volume":"84","author":"Yu","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib66","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1038\/s41467-023-40208-x","article-title":"Compilation of reported protein changes in the brain in Alzheimer's disease","volume":"14","author":"Askenazi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100983_bib68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1074\/jbc.M507378200","article-title":"Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3","volume":"281","author":"Fifre","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib69","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1038\/s41467-020-17405-z","article-title":"Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease","volume":"11","author":"Beckmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100983_bib70","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1523\/JNEUROSCI.3129-20.2021","article-title":"Regulation of synapse weakening through interactions of the microtubule associated protein tau with PACSIN1","volume":"41","author":"Regan","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcpro.2025.100983_bib71","article-title":"The AD knowledge portal: a repository for multi-omic data on Alzheimer's disease and aging","volume":"108","author":"Greenwood","year":"2020","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.mcpro.2025.100983_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/alz.046129","article-title":"Agora: an open platform for exploration of Alzheimer's disease evidence","volume":"16","author":"Greenwood","year":"2020","journal-title":"Alzheimer's Demen."},{"key":"10.1016\/j.mcpro.2025.100983_bib73","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1073\/pnas.0911073107","article-title":"Regulation of synaptic vesicle recycling by complex formation between intersectin 1 and the clathrin adaptor complex AP2","volume":"107","author":"Pechstein","year":"2010","journal-title":"P Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib74","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/364346a0","article-title":"Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein","volume":"364","author":"McMahon","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.100983_bib75","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.22-14-05900.2002","article-title":"Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis","volume":"22","author":"Guo","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcpro.2025.100983_bib76","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ana.26676","article-title":"Associations of VGF with neuropathologies and cognitive health in older adults","volume":"94","author":"Yu","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-0357-x","article-title":"VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice","volume":"15","author":"El Gaamouch","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcpro.2025.100983_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fendo.2015.00003","article-title":"Neuroendocrine role for VGF","volume":"6","author":"Lewis","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.mcpro.2025.100983_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab261","article-title":"VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases","volume":"3","author":"Quinn","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.mcpro.2025.100983_bib80","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.redox.2014.12.013","article-title":"High membrane protein oxidation in the human cerebral cortex","volume":"4","author":"Granold","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.mcpro.2025.100983_bib81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0306-4522(00)00580-7","article-title":"Protein oxidation in the brain in Alzheimer's disease","volume":"103","author":"Aksenov","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcpro.2025.100983_bib82","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1073\/pnas.94.7.2969","article-title":"Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems","volume":"94","author":"Chao","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib83","article-title":"Using redox proteomics to gain new insights into neurodegenerative disease and protein modification","volume":"13","author":"Cadenas-Garrido","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.mcpro.2025.100983_bib84","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1073\/pnas.0901931106","article-title":"Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans","volume":"106","author":"Arnesen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib85","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1021\/acs.analchem.5b04509","article-title":"FLEXITau: quantifying post-translational modifications of tau protein in vitro and in human disease","volume":"88","author":"Mair","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib86","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.100983_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/0471140864.ps2307s77","article-title":"Middle-down and top-down mass spectrometric analysis of Co-occurring histone modifications","volume":"77","author":"Molden","year":"2014","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.mcpro.2025.100983_bib88","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1021\/acs.analchem.5b00072","article-title":"Bottom-up and middle-down proteomics have comparable accuracies in defining histone post-translational modification relative abundance and stoichiometry","volume":"87","author":"Sidoli","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib89","doi-asserted-by":"crossref","first-page":"23104","DOI":"10.1021\/jacs.2c10697","article-title":"Middle-down mass spectrometry reveals activity-modifying phosphorylation barcode in a class C G protein-coupled receptor","volume":"144","author":"Ives","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mcpro.2025.100983_bib90","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1021\/ac4036857","article-title":"Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry","volume":"86","author":"Fornelli","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib91","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/acs.jproteome.6b00698","article-title":"Advancing top-down analysis of the human proteome using a benchtop quadrupole-orbitrap mass spectrometer","volume":"16","author":"Fornelli","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib92","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/jasms.0c00464","article-title":"Quantitative top-down proteomics in complex samples using protein-level tandem mass tag labeling","volume":"32","author":"Yu","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.mcpro.2025.100983_bib93","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2025.100983_bib94","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mas.20281","article-title":"The use of mass spectrometry to study amyloid-beta peptides","volume":"30","author":"Grasso","year":"2011","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.mcpro.2025.100983_bib95","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1038\/s41598-017-10422-x","article-title":"Diversity of amyloid-beta proteoforms in the Alzheimer's disease brain","volume":"7","author":"Wildburger","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcpro.2025.100983_bib96","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41592-024-02481-6","article-title":"Influence of different sample preparation approaches on proteoform identification by top-down proteomics","volume":"21","author":"Kaulich","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mcpro.2025.100983_bib97","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/psc.2391","article-title":"Hexafluoroisopropanol induces self-assembly of beta-amyloid peptides into highly ordered nanostructures","volume":"18","author":"Pachahara","year":"2012","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.mcpro.2025.100983_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47514-w","article-title":"Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view","volume":"13","author":"Zyla","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcpro.2025.100983_bib99","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2222081120","article-title":"High sensitivity top-down proteomics captures single muscle cell heterogeneity in large proteoforms","volume":"120","author":"Melby","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40478-017-0477-x","article-title":"Distinct deposition of amyloid-beta species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry","volume":"5","author":"Kakuda","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.mcpro.2025.100983_bib101","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00401-012-1061-x","article-title":"APP mutations in the Abeta coding region are associated with abundant cerebral deposition of Abeta38","volume":"124","author":"Moro","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcpro.2025.100983_bib102","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-4159.1988.tb01087.x","article-title":"Differences between vascular and plaque core amyloid in Alzheimer's disease","volume":"51","author":"Prelli","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcpro.2025.100983_bib103","first-page":"452","article-title":"High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy","volume":"145","author":"Suzuki","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcpro.2025.100983_bib104","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcpro.2025.100983_bib105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14283\/jpad.2018.41","article-title":"Plasma Abeta42\/40 ratio detects early stages of Alzheimer's disease and correlates with CSF and neuroimaging biomarkers in the AB255 study","volume":"6","author":"Perez-Grijalba","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.mcpro.2025.100983_bib106","first-page":"e688","article-title":"Validation of plasma amyloid-beta 42\/40 for detecting Alzheimer disease amyloid plaques","volume":"98","author":"Li","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.mcpro.2025.100983_bib107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-022-00967-z","article-title":"The Abeta1-42\/Abeta1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Abeta1-42 alone","volume":"14","author":"Delaby","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.mcpro.2025.100983_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1364658","article-title":"Clinical utility of plasma Abeta42\/40 ratio by LC-MS\/MS in Alzheimer's disease assessment","volume":"15","author":"Weber","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib109","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1021\/bi900818a","article-title":"Pyroglutamate Formation influences solubility and amyloidogenicity of amyloid peptides","volume":"48","author":"Schlenzig","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.mcpro.2025.100983_bib110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jpba.2006.05.008","article-title":"Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development","volume":"42","author":"Yu","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.mcpro.2025.100983_bib111","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.84.11.3628","article-title":"Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides","volume":"84","author":"Fischer","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib112","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1016\/S0021-9258(18)47446-7","article-title":"An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes","volume":"262","author":"Busby","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2025.100983_bib113","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1471-4159.2008.05471.x","article-title":"Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical\/hippocampal microinjection in vivo\/in situ","volume":"106","author":"Schilling","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcpro.2025.100983_bib114","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcpro.2025.100983_bib115","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res."},{"key":"10.1016\/j.mcpro.2025.100983_bib116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801\u2014the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.mcpro.2025.100983_bib117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.14283\/jpad.2019.21","article-title":"Plasma biomarkers of AD emerging as essential tools for drug development: an EU\/US CTAD task force report","volume":"6","author":"Bateman","year":"2019","journal-title":"J. Prev. Alzheimer's Dis."},{"key":"10.1016\/j.mcpro.2025.100983_bib118","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.mcpro.2025.100983_bib119","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer's disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.mcpro.2025.100983_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-beta on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer's disease","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcpro.2025.100983_bib121","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2011.11.047","article-title":"Structural basis of C-terminal beta-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease","volume":"421","author":"La Porte","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mcpro.2025.100983_bib122","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/acn3.761","article-title":"Immunotherapy with ponezumab for probable cerebral amyloid angiopathy","volume":"6","author":"Leurent","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib123","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1474-4422(21)00213-1","article-title":"Off-label use of aducanumab for cerebral amyloid angiopathy","volume":"20","author":"Greenberg","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib124","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcpro.2025.100983_bib125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2025.100983_bib126","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","article-title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-beta","volume":"8","author":"Arndt","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcpro.2025.100983_bib127","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/STROKEAHA.121.036873","article-title":"Vessels sing their ARIAs: the role of vascular amyloid in the age of aducanumab","volume":"53","author":"Sveikata","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.mcpro.2025.100983_bib128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mcpro.2025.100983_bib129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jchemneu.2011.05.007","article-title":"VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers","volume":"42","author":"Ferri","year":"2011","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.mcpro.2025.100983_bib130","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1523\/JNEUROSCI.0584-15.2015","article-title":"VGF and its C-terminal peptide TLQP-62 regulate memory formation in Hippocampus via a BDNF-TrkB-dependent mechanism","volume":"35","author":"Lin","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcpro.2025.100983_bib131","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0955-0674(01)00289-7","article-title":"The oncoprotein 18\/stathmin family of microtubule destabilizers","volume":"14","author":"Cassimeris","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mcpro.2025.100983_bib132","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1038\/ncomms5389","article-title":"Learning-induced and stathmin-dependent changes in microtubule stability are critical for memory and disrupted in ageing","volume":"5","author":"Uchida","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100983_bib133","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0197-4580(96)00021-8","article-title":"Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease","volume":"17","author":"Jin","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcpro.2025.100983_bib134","series-title":"Protein Expression in Down Syndrome Brain","first-page":"281","article-title":"Gert Lubec","author":"Cheon","year":"2001"},{"key":"10.1016\/j.mcpro.2025.100983_bib135","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.90.23.11187","article-title":"Altered phosphorylation of growth-associated protein B50\/GAP-43 in Alzheimer disease with high neurofibrillary tangle density","volume":"90","author":"Martzen","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2025.100983_bib136","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1016\/S0021-9258(19)50388-X","article-title":"GAP-43, a protein associated with axon growth, is phosphorylated at three sites in cultured neurons and rat brain","volume":"267","author":"Spencer","year":"1992","journal-title":"J. Biol. Chem."}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:08:36Z","timestamp":1762549716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947625000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":135,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1535947625000817"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.100983","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Proteoforms Associated With Alzheimer's Disease Through Quantitative Top-Down Proteomics","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.100983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100983"}}